Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-Biogen presents data from Phase 1b study of investigational Alzheimer's Disease Treatment at 2016 clinical trials on Alzheimer's Disease Meeting

By: Reuters: Company News
* Biogen presents data from Phase 1b study of investigational Alzheimer's disease treatment Aducanumab at 2016 clinical trials on Alzheimer's Disease Meeting
Related Stocks:
Biogen Idec
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.